Use of Registries, Claims and Health System Data to Enhance the Evaluation of Cardiovascular Therapies in Clinical Trials
使用注册、索赔和卫生系统数据来加强临床试验中心血管治疗的评估
基本信息
- 批准号:9897550
- 负责人:
- 金额:$ 79.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAmericanAreaCardiacCardiologyCardiovascular systemCaringCharacteristicsClinicalClinical ResearchClinical TrialsClinical Trials Cooperative GroupCollaborationsCommon Data ElementCommunitiesComplementCoronaryDataData SetData SourcesDatabasesDevicesEffectivenessEnrollmentEvaluationFutureGoalsGoldHealthHealth systemHeart Valve DiseasesHospitalizationHospitalsInfrastructureInsurance CarriersInterventionIsraelLinkMeasuresMedicalMedical centerMethodsMulti-Institutional Clinical TrialOutcomeOutcomes ResearchPatient CarePatient RepresentativePatient-Focused OutcomesPatientsPharmaceutical PreparationsPopulationProbabilityProceduresPublic HealthPublic Health SchoolsRandomizedRegistriesResearchResearch DesignResearch InstituteResourcesRisk FactorsRisk stratificationSafetySourceStentsSubgroupTestingTimeValidationWeightaortic valve replacementbasecardiovascular healthclinical careclinical practicecollegecomparativecostdata registryfrailtyhealth care qualityhigh dimensionalityimprovedindividual patientinsightnovelpatient subsetspersonalized carepopulation basedpost-marketprogramsroutine caretreatment effecttreatment responsetreatment strategytrial comparing
项目摘要
PROJECT SUMMARY/ABSTRACT
The timely and efficient evaluation of new medical treatment strategies, therapies and devices is critical to
improving public health. Ubiquitous data collected in the routine care of patients, including registries, health
systems and payers, remain underutilized sources of information that could be used to support clinical trial
evaluations of novel medical interventions, but require validation. Through a collaboration involving the Smith
Center for Outcomes Research at Beth Israel Deaconess Medical Center, Harvard Clinical Research Institute,
the Harvard T.H. Chan School of Public Health, the American College of Cardiology (ACC), Premier, Inc.,
Symphony Health Solutions and Medtronic, we will combine data from two landmark clinical trial programs -
the Dual Antiplatelet Therapy (DAPT) Study and the US CoreValve Trials - with comprehensive national data
from registries, health systems and payers, to test several hypotheses central to the future evaluation of
cardiovascular therapies. In Aim 1, we will test the hypothesis that trial outcomes derived from linked registry,
hospital, and claims data will be equivalent to outcomes obtained in clinical trials, suggesting that these
alternative data sources can, in some cases, replace traditional clinical trial data. In Aim 2, we will test the
hypothesis that information collected through registries, hospitals, and claims that was not collected in the
original clinical trial, such as prior non-cardiac hospitalizations and markers of frailty, can augment trial data,
through improved risk stratification and identification of heterogeneous treatment effects. In Aim 3, we will
leverage the linkage of trials with population-based datasets to enable the creation of novel and broadly
applicable metrics to assess overall trial generalizability and applicability to understudied subgroups. The
linkage of these diverse resources will create an important opportunity to formally evaluate the strengths and
limitations of using non-clinical trial data sources to support and improve clinical trial assessments of medical
therapies. The information learned has the potential to greatly inform the future conduct of pragmatic and
naturalistic clinical trials, while offering novel insights into the efficacy and safety of therapies to treat coronary
and valvular heart disease.
项目摘要/摘要
及时和有效地评估新的医疗治疗策略、疗法和设备对于
改善公共卫生。在患者常规护理中收集的无处不在的数据,包括登记表、健康状况
系统和付款人,仍然没有充分利用可用于支持临床试验的信息来源
对新的医疗干预措施的评估,但需要验证。通过史密斯夫妇的合作
贝丝以色列女执事医学中心结果研究中心,哈佛临床研究所,
哈佛大学公共卫生学院、美国心脏病学会(ACC)、Premier,Inc.
我们将结合来自两个具有里程碑意义的临床试验项目的数据-
双重抗血小板治疗(DAPT)研究和美国CoreValve试验--综合国家数据
来自登记机构、卫生系统和付款人,以检验几个对未来评估
心血管治疗。在目标1中,我们将检验试验结果来自关联登记的假设,
医院,并声称数据将等同于在临床试验中获得的结果,表明这些
在某些情况下,替代数据源可以取代传统的临床试验数据。在目标2中,我们将测试
假设通过登记处、医院和索赔收集的信息不是在
最初的临床试验,例如以前的非心脏住院和虚弱的标志,可以增加试验数据,
通过改进风险分层和确定异质治疗效果。在《目标3》中,我们将
利用试验与基于人口的数据集的联系,能够创建新的和广泛的
评估总体试验的概括性和对未被研究的亚组的适用性的适用指标。这个
这些不同资源的联系将创造一个重要机会,以正式评估优势和
使用非临床试验数据来源支持和改进医学临床试验评估的局限性
治疗。所学到的信息有可能极大地指导未来的务实和
自然主义临床试验,同时为治疗冠心病的有效性和安全性提供了新的见解
和心脏瓣膜病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Yeh其他文献
Robert Yeh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Yeh', 18)}}的其他基金
Using Claims-Based Signatures of Frailty to Support Individualized Treatment of Aortic Valve Stenosis and Coronary Artery Disease
使用基于索赔的虚弱特征来支持主动脉瓣狭窄和冠状动脉疾病的个体化治疗
- 批准号:
10363612 - 财政年份:2020
- 资助金额:
$ 79.1万 - 项目类别:
Using Claims-Based Signatures of Frailty to Support Individualized Treatment of Aortic Valve Stenosis and Coronary Artery Disease
使用基于索赔的虚弱特征来支持主动脉瓣狭窄和冠状动脉疾病的个体化治疗
- 批准号:
10545062 - 财政年份:2020
- 资助金额:
$ 79.1万 - 项目类别:
Balancing the Risks of Ischemia and Bleeding in Percutaneous Coronary Interventio
平衡经皮冠状动脉介入治疗中的缺血和出血风险
- 批准号:
9216363 - 财政年份:2013
- 资助金额:
$ 79.1万 - 项目类别:
Balancing the Risks of Ischemia and Bleeding in Percutaneous Coronary Interventio
平衡经皮冠状动脉介入治疗中的缺血和出血风险
- 批准号:
8487063 - 财政年份:2013
- 资助金额:
$ 79.1万 - 项目类别:
Balancing the Risks of Ischemia and Bleeding in Percutaneous Coronary Interventio
平衡经皮冠状动脉介入治疗中的缺血和出血风险
- 批准号:
8724553 - 财政年份:2013
- 资助金额:
$ 79.1万 - 项目类别:
Balancing the Risks of Ischemia and Bleeding in Percutaneous Coronary Interventio
平衡经皮冠状动脉介入治疗中的缺血和出血风险
- 批准号:
8842697 - 财政年份:2013
- 资助金额:
$ 79.1万 - 项目类别:
相似海外基金
Asian American Community Cohort of the New York Metropolitan Area
纽约都会区亚裔美国人社区群体
- 批准号:
10724342 - 财政年份:2023
- 资助金额:
$ 79.1万 - 项目类别:
Individual, cultural, and area-based factors associated with survivorship care among Asian/Asian American childhood cancer survivors
与亚裔/亚裔美国儿童癌症幸存者的生存护理相关的个人、文化和地区因素
- 批准号:
10693965 - 财政年份:2021
- 资助金额:
$ 79.1万 - 项目类别:
Individual, cultural, and area-based factors associated with survivorship care among Asian/Asian American childhood cancer survivors
与亚裔/亚裔美国儿童癌症幸存者的生存护理相关的个人、文化和地区因素
- 批准号:
10482384 - 财政年份:2021
- 资助金额:
$ 79.1万 - 项目类别:
Individual, cultural, and area-based factors associated with survivorship care among Asian/Asian American childhood cancer survivors
与亚裔/亚裔美国儿童癌症幸存者的生存护理相关的个人、文化和地区因素
- 批准号:
10275095 - 财政年份:2021
- 资助金额:
$ 79.1万 - 项目类别:
Adaptation of the US-American pediatric Patient-Reported Outcome Measurement Information System (PROMIS) for the German speaking area
美国儿科患者报告结果测量信息系统 (PROMIS) 适应德语地区
- 批准号:
271504683 - 财政年份:2015
- 资助金额:
$ 79.1万 - 项目类别:
Research Grants
Transnationalism in American Studies and Future of Area Studies
美国研究中的跨国主义和区域研究的未来
- 批准号:
15K01898 - 财政年份:2015
- 资助金额:
$ 79.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Evaluating Area-Based Socioeconomic Measures from American Community Survey data
根据美国社区调查数据评估基于地区的社会经济措施
- 批准号:
8565162 - 财政年份:2012
- 资助金额:
$ 79.1万 - 项目类别:
Doctoral Dissertation Improvement Grant: Clovis Settlement Behavior in the American Southeast: Using Lithic Artifact Analysis to Evaluate the Staging-Area Model
博士论文改进补助金:美国东南部的克洛维斯定居点行为:利用石器文物分析来评估集结区模型
- 批准号:
0852946 - 财政年份:2008
- 资助金额:
$ 79.1万 - 项目类别:
Standard Grant
Inter-American materials research - Thin film materials for large area encapsulation barriers for flexible organic electronics
美洲材料研究 - 用于柔性有机电子器件大面积封装屏障的薄膜材料
- 批准号:
312945-2005 - 财政年份:2007
- 资助金额:
$ 79.1万 - 项目类别:
Special Research Opportunity Program - Inter-American Collaboration in Materials Research
Inter-American materials research - Thin film materials for large area encapsulation barriers for flexible organic electronics
美洲材料研究 - 用于柔性有机电子大面积封装屏障的薄膜材料
- 批准号:
312945-2005 - 财政年份:2006
- 资助金额:
$ 79.1万 - 项目类别:
Special Research Opportunity Program - Inter-American Collaboration in Materials Research














{{item.name}}会员




